NasdaqGS - Nasdaq Real Time Price USD
Seer, Inc. (SEER)
1.8750
-0.0150
(-0.79%)
As of 3:00:18 PM EDT. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | -0.36 | -0.37 | -1.44 | -1.26 |
Low Estimate | -0.39 | -0.39 | -1.54 | -1.5 |
High Estimate | -0.35 | -0.35 | -1.36 | -0.82 |
Year Ago EPS | -0.32 | -0.35 | -1.39 | -1.44 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 3 | 3 |
Avg. Estimate | 3.25M | 4.05M | 17.52M | 24.69M |
Low Estimate | 3M | 4M | 17.47M | 23.01M |
High Estimate | 3.5M | 4.1M | 17.6M | 27.95M |
Year Ago Sales | 3.07M | 3.07M | 14.17M | 17.52M |
Sales Growth (year/est) | 6.00% | 31.84% | 23.62% | 40.94% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -0.3 | -0.36 | -0.31 | -0.39 |
EPS Actual | -0.32 | -0.35 | -0.35 | -0.37 |
Difference | -0.02 | 0.01 | -0.04 | 0.02 |
Surprise % | -6.33% | 2.88% | -13.50% | 4.41% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.36 | -0.37 | -1.44 | -1.26 |
7 Days Ago | -0.37 | -0.39 | -1.46 | -1.3 |
30 Days Ago | -0.34 | -0.35 | -1.58 | -1.27 |
60 Days Ago | -0.34 | -0.35 | -1.58 | -1.27 |
90 Days Ago | -0.34 | -0.37 | -1.57 | -1.32 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | 1 |
Up Last 30 Days | -- | -- | 3 | 2 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
SEER | -13.07% | -7.03% | -3.28% | 12.18% |
S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 8/13/2024 |
Maintains | Morgan Stanley: Equal-Weight | 2/21/2023 |
Downgrade | B of A Securities: Neutral to Underperform | 1/4/2023 |
Maintains | Morgan Stanley: Equal-Weight | 11/10/2022 |
Maintains | Morgan Stanley: Equal-Weight | 8/11/2022 |
Downgrade | JP Morgan: Overweight to Neutral | 8/11/2022 |
Related Tickers
ANTX AN2 Therapeutics, Inc.
1.1800
-3.28%
HLVX HilleVax, Inc.
1.9050
-0.26%
PMVP PMV Pharmaceuticals, Inc.
0.9000
+1.83%
EPIX ESSA Pharma Inc.
1.7200
+0.58%
KZR Kezar Life Sciences, Inc.
4.2500
+3.16%
LVTX LAVA Therapeutics N.V.
1.2900
+1.57%
TBPH Theravance Biopharma, Inc.
8.90
-10.10%
SPRO Spero Therapeutics, Inc.
0.6200
+7.56%
IPSC Century Therapeutics, Inc.
0.5298
+1.88%
ASMB Assembly Biosciences, Inc.
12.30
+5.45%